Should You Buy Moderna Before Feb. 13?
(NASDAQ: MRNA) has been on fire this year, with the biotech's shares up by 39% through Feb. 6. This isn't due to the company's financial results. Moderna has yet to release its fourth-quarter 2025 update. That's coming up on Feb. 13.
And although it provided guidance for 2025, that was months ago and wasn't nearly spectacular enough to jolt the stock this much. What's driving Moderna's performance in 2026? And should investors buy the stock before its next quarterly update? Let's take a look.
Image source: Getty Images.
Source Fool.com
Moderna Inc. Aktie
51,36 €
0,37 %
Leichte Kaufstimmung für Moderna Inc.: Mehr Buy- als Sell-Einschätzungen.
Das Kursziel von 21 € für Moderna Inc. liegt unter dem aktuellen Kurs von 51.36 €, ergibt aber ein negatives Potenzial von -59.11%.
